glp-1 liver fibrosis The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis Semaglutide Heals Liver Fat and

Gut microbiota metabolite trimethylamine N-oxide promoted NAFLD progression by exacerbating intestinal barrier disruption and intrahepatic cellular imbalance

vascular infiltration of hepatocytes

Together, these effects highlight the capacity of KD to preserve dopaminergic neurons by directly interfering with apoptotic signaling cascades in PD

Weight Management programs are designed with weight reduction as the primary goal and typically use dosing strategies intended to support clinically significant weight loss

SGLT2 inhibitors and GLP-1 agonists should be used as early as possible in the diabetes course to provide the most cardiac benefit, Joanna Khatib, MBBS, an endocrinology fellow at Tulane University School of Medicine, told Healio